GlassScriptPhysician profile
Raymond K Weber
NPI 1992702286
$919.97
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $90.56 | 2019 | |
| Lilly USA, LLC | $88.40 | 2019 | |
| Amgen INC. | $81.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.06 | 2019 | |
| Allergan, INC. | $56.61 | 2019 | |
| Arbor Pharmaceuticals, INC. | $53.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $52.47 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $43.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.08 | 2019 | |
| Celgene Corporation | $40.32 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.78 | 2019 | |
| Amarin Pharma, INC. | $36.64 | 2019 | |
| Abbvie INC. | $33.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.67 | 2019 | |
| Novo Nordisk INC | $29.64 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $24.74 | 2019 | |
| Bausch Health US, LLC | $21.71 | 2019 | |
| Mylan Specialty L.P. | $20.85 | 2019 | |
| Sanofi Pasteur INC. | $14.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.64 | 2019 | |
| Merck Sharp & Dohme LLC | $12.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2019 | |
| Glaxosmithkline, LLC. | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.